Small Extracellular Vesicles Secreted by Human IPSC-derived MSC Enhance Angiogenesis Through Inhibiting STAT3-dependent Autophagy in Ischemic Stroke
Overview
Authors
Affiliations
Background: Small extracellular vesicles (sEV) secreted by mesenchymal stem cells (MSC) derived from human induced pluripotent stem cells (iPSC, iMSC-sEV) are considered to have great potential in treating ischemic diseases. Angiogenesis play an important role in post-stroke recovery. However, no studies have yet been conducted to systemically examine the effect and the underlying mechanism of iMSC-sEV on angiogenesis under brain ischemia conditions.
Methods: Ischemic stroke model was performed in rats induced by middle cerebral artery occlusion (MCAO), and the pro-angiogenic capacity of iMSC-sEV was measured. The in vitro effects of iMSC-sEV on the migration and tube formation of endothelial cells were investigated, respectively. Autophagy and autophagy-related signaling pathway were detected in vivo and in vitro.
Results: We found that iMSC-sEV significantly reduced infarct volume, enhanced angiogenesis, and alleviated long-term neurological deficits in rats after stroke. We also demonstrated that iMSC-sEV increased migration and tube formation of endothelial cells in vitro. A further mechanism study revealed that the pro-angiogenic effect of iMSC-sEV was correlated with a reduction in autophagy. Furthermore, iMSC-sEV significantly activated signal transducer and activator of transcription 3 (STAT3), and suppression of STAT3 abolished iMSC-sEV-induced inhibition of autophagy and promotion of angiogenesis in vivo and in vitro.
Conclusions: Taken together, our data indicate that iMSC-sEV promote angiogenesis after ischemic stroke, potentially, by inhibiting autophagy, a process that is partially dependent on STAT3 activation.
Garcia-Martinez T, Gornatti D, Ortiz M, Canellas G, Heine-Suner D, Vives-Bauza C Int J Mol Sci. 2025; 26(5).
PMID: 40076511 PMC: 11900453. DOI: 10.3390/ijms26051886.
Hoseinzadeh A, Esmaeili S, Sahebi R, Melak A, Mahmoudi M, Hasannia M Stem Cell Res Ther. 2025; 16(1):33.
PMID: 39901306 PMC: 11792531. DOI: 10.1186/s13287-025-04158-z.
Li Y, Quan X, Hu J, Han Y, Chen J, Zhou M Int J Biol Sci. 2025; 21(2):842-859.
PMID: 39781452 PMC: 11705626. DOI: 10.7150/ijbs.101937.
Molecular Targeting of Ischemic Stroke: The Promise of Naïve and Engineered Extracellular Vesicles.
Lee J, Geum D, Park D, Kim J Pharmaceutics. 2025; 16(12.
PMID: 39771472 PMC: 11678501. DOI: 10.3390/pharmaceutics16121492.
Xu Q, Gu L, Li Z, Gao L, Wei L, Shafiq Z Neuromolecular Med. 2024; 26(1):51.
PMID: 39644405 DOI: 10.1007/s12017-024-08819-9.